WallStSmart
AQST

Aquestive Therapeutics Inc

NASDAQ: AQST · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$3.46
-6.61% today

Updated 2026-11-20

Market cap
$491.44M
P/E ratio
—
P/S ratio
10.06x
EPS (TTM)
$-0.65
Dividend yield
—
52W range
$3 – $7
Volume
2.3M

Aquestive Therapeutics Inc (AQST) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$3.46
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$2.50

Financial forecast

Metric202120222023202420252027 (E)2028 (E)2029 (E)2030 (E)
Revenue$0.1B$0.0B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
EPS—————————
CAGR applied: -0.58% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -162.30%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.